Browse the full management transaction log of 프롬바이오, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 프롬바이오 has published 27 public disclosures. The latest transaction was disclosed on 6 February 2026 (Other). Among the most active insiders: 심태진. All data is openly available.
27
Insider Decl.
0
Thresholds
·
14 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.